Tier 4

Small-Volume Parenterals

Indicative CAPEX

$5M – $40M

Market position

None

ampoules/vials manufactured in Tanzania

No ampoules or vials are manufactured in Tanzania today, yet injectable generics are among the highest-volume lines in MSD procurement. A small-volume parenterals plant is a compact, high-margin investment with a clear regulatory pathway through TMDA's 60-day fast-track. Sterile sub-zone B3 inside the Pharmaceutical Core is purpose-zoned for exactly this use.

Why this tier

Purpose-zoned sterile sub-zone B3 (45 acres) ready for allocation
High-volume injectable demand in national procurement
Compact CAPEX with fast TMDA registration pathway

Next steps

Review the regulatory pathway · See the incentive package

Submit EOI for this tier